Article
High quality clinical grade human embryonic stem cell lines derived from fresh discarded embryos
5 Jun 2017
Abstract excerpt
BACKGROUND: Human embryonic stem cells (hESCs) hold tremendous promise for cell replacement therapies for a range of degenerative diseases. In order to provide cost-effective treatments affordable by public health systems, HLA-matched allogeneic tissue banks of the highest quality clinical-grade hESCs will be required. However only a small number of existing hESC lines are suitable for clinical use; they are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
